Key Highlights

  • Shares are trading 19.16% higher at $13.97 on Thursday, October 29, 2026.
  • Third-quarter revenue grew 22.7% to $375.9 million from $306.5 million.
  • Adjusted EBITDA advanced 35.8% to $39.5 million, and diluted EPS came in at $0.46 against $0.26.
  • Fourth-quarter revenue guidance is $355 million to $375 million, with adjusted EBITDA of $36.0 million to $39.0 million.
  • Free cash flow for full-year 2026 is guided at $90 million to $100 million.

MediaAlpha Gains 19.16% Following Its Earnings Report: What Moved the Stock?

MediaAlpha (NYSE:MAX) shares are trading 19.16% higher at $13.97 on Thursday, October 29, 2026, which implies a prior close near $11.72 (calculated). The company issued third-quarter 2026 results on Wednesday, October 28 and held its call that afternoon.

MediaAlpha runs a programmatic customer acquisition platform for the insurance industry, linking carriers with online shoppers via brand, comparison and metasearch sites. It cites more than 1,150 active partners and over 141 million consumer referrals in 2025, when its technology powered $2.2 billion of spend.

Profit Outpaces Sales in the Third Quarter: A Closer Look at the Figures

Third-quarter revenue grew 22.7% to $375.9 million. Gross profit rose 27.5% to $55.3 million, a 14.7% margin compared with 14.2%, while contribution increased 25.8% to $57.4 million at a 15.3% margin.

Net income reached $29.4 million, a 66.4% increase, with $25.8 million attributable to the company versus $14.9 million. Diluted EPS for Class A shares was $0.46 against $0.26, and operating income climbed to $28.8 million from $19.7 million. Adjusted EBITDA advanced 35.8% to $39.5 million from $29.1 million.

A $10.7 million gain from repurchasing tax receivable agreement interests added to net income.

Nine-Month Totals and the Fourth-Quarter Guide: What the Outlook Implies

Nine-month revenue totaled $1,002.8 million against $822.4 million, and adjusted EBITDA was $100.1 million against $83.0 million. Net income was $85.2 million compared with a $7.2 million loss, helped by a $48.4 million nine-month gain from the tax receivable agreement repurchases.

For the fourth quarter, management guided revenue to $355 million to $375 million, about 25% growth at the midpoint, contribution to $54.0 million to $57.0 million and adjusted EBITDA to $36.0 million to $39.0 million, about 22% growth at the midpoint. Without under-65 health insurance, contribution is expected to rise about 21% and adjusted EBITDA about 26%, and health should be about 4% of fourth-quarter revenue.

Free cash flow for the full year is guided at $90 million to $100 million.

Repurchases Against a Thinner Cash Position: How the Balance Sheet Looks

In the third quarter it repurchased about 0.8 million shares for $9 million. Under the $100 million authorization, $64 million covering 6.2 million shares had been used by September 30, and $82 million was complete as of October 26. Since September 2025 it has bought back $115 million of stock.

Cash declined to $18.7 million from $46.9 million at the end of 2025, and total debt grew to about $174.9 million from about $153.4 million. Stockholders' equity turned positive at $19.8 million from a $29.2 million deficit.

Next Checkpoints: Can Fourth-Quarter Results Land Within the Guided Ranges?

Upcoming markers include the fourth-quarter report, where revenue of $355 million to $375 million and adjusted EBITDA of $36.0 million to $39.0 million are the stated targets, the capacity left under the $100 million buyback, and the seasonal health enrollment period. Cash conversion toward the $90 million to $100 million free cash flow range and the debt balance will also shape year-end.